These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6692744)

  • 21. Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.
    Paik YH; Lee KS; Han KH; Song KH; Kim MH; Moon BS; Ahn SH; Lee SJ; Park HJ; Lee DK; Chon CY; Lee SI; Moon YM
    Yonsei Med J; 2005 Jun; 46(3):399-407. PubMed ID: 15988813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY; Hawley KE
    Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.
    Bucci L; Palmieri GC
    Curr Med Res Opin; 1993; 13(2):109-18. PubMed ID: 8325041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy.
    Hasan S; Datta S; Bhattacherjee S; Banik S; Saha S; Bandyopadhyay D
    J Assoc Physicians India; 2018 Jan; 66(1):32-6. PubMed ID: 30341842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we ignore minimal hepatic encephalopathy any longer?
    Qadri AM; Ogunwale BO; Mullen KD
    Hepatology; 2007 Mar; 45(3):547-8. PubMed ID: 17326151
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J; Prónai L
    Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic encephalopathy evaluated by automatic period analysis of the electroencephalogram during lactulose treatment.
    Kardel T; Olsen PZ; Stigsby B; Tonnesen K
    Acta Med Scand; 1972 Dec; 192(6):493-8. PubMed ID: 4640695
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.
    Orlandi F; Freddara U; Candelaresi MT; Morettini A; Corazza GR; Di Simone A; Dobrilla G; Cavallini G
    Dig Dis Sci; 1981 Jun; 26(6):498-506. PubMed ID: 7016484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactulose in baby milks.
    Hendrickse RG
    Br Med J; 1977 Jul; 2(6080):187. PubMed ID: 577474
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of lactulose in portal-systemic encephalopathy.
    Matthews SJ
    Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
    [No Abstract]   [Full Text] [Related]  

  • 33. Lactulose in baby milks causing diarrhoea simulating lactose intolerance.
    Hendrickse RG; Wooldridge MA; Russell A
    Br Med J; 1977 May; 1(6070):1194-5. PubMed ID: 861533
    [No Abstract]   [Full Text] [Related]  

  • 34. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rectal administration of lactulose.
    Ratnaike RN; Hicks EP; Hislop IG
    Aust N Z J Med; 1975 Apr; 5(2):137-40. PubMed ID: 240347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 37. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
    Morgan MY; Hawley KE; Stambuk D
    J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.
    McClain CJ; Potter TJ; Kromhout JP; Zieve L
    J Clin Gastroenterol; 1984 Aug; 6(4):325-9. PubMed ID: 6481115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.